Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
Milrinone Lactate in 5% Dextrose Injection in INTRAVIA Plastic Container
Medication labelWhy this: Advisory · dailymed-prescription
Milrinone is indicated for the short-term intravenous treatment of patients with acute decompensated heart failure. Patients receiving milrinone should be observed closely with appropriate electrocardiographic equipment. The facility for immediate treatment of potential cardiac events, which may include life-threatening ventricular arrythmias, must be available. The majority of experience with intravenous milrinone has been in patients receiving digoxin and diuretics. There is no experience in controlled trials with infusions of milrinone for periods exceeding 48 hours.
- generic_name
- milrinone lactate
- product_names
- MILRINONE LACTATE
- ndc
- 0338-6010, 0338-6011, 0338-6010-48, 0338-6011-37
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en